NEW YORK (GenomeWeb News) – Researchers at Albert Einstein College of Medicine will use two CLC Bio software platforms in its epigenomics and other research programs under a new site license agreement, the Danish company said today.
CLC Bio said that the College's Einstein Center for Epigenomics will use its Genomics Workbench and its Genomics Server to handle data it generates in its high-throughput sequencing programs.
John Greally, director of the Bronx, NY-based Einstein Center for Epigenomics, said in a statement that the software will enhance the researchers' ability to explore massively parallel sequencing data being generated at the center. He added that using the software platforms is "a way of lowering barriers for scientists who have not previously performed these high-throughput epigenomics assays, allowing them to explore their data and explore hypotheses."
Financial terms of the agreement were not released.
The two CLC Bio platforms can be used to analyze and visualize data from Applied Biosystems' SOLiD, Illumina's Genome Analyzer, Roche 454's Genome Sequencer, and Helicos' HeliScope system.